The positron emission tomography (PET) scanners market is estimated to be valued at US$ 1.3 billion in 2023 and is rising to US$ 2.1 billion by 2033. The market is likely to grow at a CAGR of 5.3% during the forecast period. Various factors driving the market for positron emission tomography (PET) scanners are:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Although the efficacy of PET scanners has been established, continuous reimbursement cutbacks are affecting the market's growth. Players have been declined reimbursement for these products worldwide, which has resulted in a reduced number for outpatient volume, thus affecting access to high-quality and cost-effective diagnostic imaging services.
Apart from this, radiopharmaceuticals used during PET scanning procedures have a short life. The systems utilize radioisotope tracers to gain better imaging capabilities, thus providing more specific information about organ function or dysfunction.
The most common radiotracer is fluorodeoxyglucose (FDG), which incorporates fluorine-18 as a tracer. It is the most used radiotracer in PET scanning and imaging. However, the radiotracer has a half-life of just under 2 hours, limiting its utility.
The growing adoption of PET and X-ray transmission computed tomography (CT) scans is expected to boost the market in the forthcoming years. This innovative technology reduces acquisition time and provides precise attenuation correction and fusion imaging, resulting in high diagnostic sensitivity and specificity.
Moreover, the combination of PET and CT helps in the better staging of disease by defining prognostic and treatment monitoring capabilities of the functional and metabolic information given by conventional nuclear imaging techniques. Most PET scanning procedures use fluorodeoxyglucose (FDG) as it can capture tissue glucose metabolism and increase its parameters. However, fluorodeoxyglucose has a few shortcomings, such as low specificity.
Additionally, several potential radiotracers are under investigation to address the unmet clinical needs of diagnosis of diseases. In response, manufacturers are launching new products with higher sensitivity regarding metabolic activity to achieve detailed scans. Players are also investing in mergers and acquisitions to improve their product portfolios.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 5.3% |
| Market Valuation (2023) | US$ 1.3 billion |
| Market Valuation (2033) | US$ 2.1 billion |
Principal Consultant
Future Market Insights projects the global emission tomography (PET) scanners market to expand at a healthy 5.3% CAGR during the forecast period. Historically, the market registered a CAGR of 4.6% between 2017 and 2022.
Short Term (2022 to 2025): Increasing demand for radiopharmaceuticals, integrating computed tomography with PET, and advancements in hybrid imaging systems boost the market expansion.
Medium Term (2025 to 2028): PET scanners employ a type of nuclear medicine process to measure the metabolic activity of the body tissues and cells. They are mostly used in patients with heart or brain conditions and cancer. The process involves visualization of biochemical changes in the body, such as the metabolism of the heart muscle.
Long Term (2028 to 2033): PET scanners are widely adopted due to their ability to visualize and quantify tumoral features on molecular levels, compared to traditional techniques. Rising awareness regarding the advantages of radiotherapy and radiation oncology and a growing disposition towards non-invasive procedures are driving market opportunities.
The market is estimated to reach US$ 2.1 billion during the forecast period. In the historical period, the market stood at a valuation of US$ 1.2 billion from 2017 to 2022.
Positron Emission Tomography (PET) Scanners Market:
| Attributes | Positron Emission Tomography (PET) Scanners Market |
|---|---|
| CAGR (2023 to 2033) | 5.3% |
| Value (2023) | US$ 1.6 billion |
| Value (2033) | US$ 3.4 billion |
| Trends | The adoption of positron emission tomography (PET) scanners detects several cancers, including breast, neck, lung, thyroid, ovarian, and cervical cancer. |
| Opportunities | The increasing innovative technology, stringent government regulations, and new market entrance drive the positron emission tomography (PET) scanners market. |
3D Scanner Market:
| Attributes | 3D Scanner Market |
|---|---|
| CAGR (2023 to 2033) | 7.5% |
| Value (2023) | US$ 1.05 billion |
| Value (2033) | US$ 2.16 billion |
| Trends | The rising demand for 3D scanners in automobile, construction, and medical sectors drives market share. |
| Opportunities | Innovation of 3D laser scanners and the rapidly growing mining industry propel market opportunities. |
CT Scanner Market:
| Attributes | CT Scanner Market |
|---|---|
| CAGR (2023 to 2033) | 4.7% |
| Value (2023) | US$ 6.49 billion |
| Value (2033) | US$ 10.27 billion |
| Trends | The growing prevalence of diseases, technical advancement, and aging population drive market share. |
| Opportunities | The rising adoption of computed tomography and preferences towards image-guided intervention increase market opportunities. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segments | Product Type |
|---|---|
| Top Category | Full-ring PET Scanner |
| Historic CAGR | 4.7% |
| Forecast CAGR | 5.2% |
| Segments | Application |
|---|---|
| Top Category | Oncology |
| Historic CAGR | 4.1% |
| Forecast CAGR | 4.9% |
Based on product type, demand for full-ring PET scanners is projected to surge at a CAGR of 5.2% during the forecast period. The product offers high efficiency and contains multiple rings of scintillator detectors. These detectors cover a full 360-degree angular rotation around the volume to be imaged. Historically, the full-ring PET scanner secured a CAGR of 4.7% between 2017 and 2022.
In terms of applications, the oncology segment dominates the global market by securing a CAGR of 4.9% during the forecast period. The adoption of PET scanners in oncology for imaging techniques is growing the market share.
The rising demand for PET scanner in clinical trials to determine therapeutic response for novel cancer are increasing the market expansion. Historically, the oncology segment captured a CAGR of 4.1% between 2017 to 2022.
Based on the detector type, sales of lutetium oxyorthosilicate (LSO) led to more than 37.3% of the total market share in 2020. The lutetium oxyorthosilicate (LSO) segment is expected to grow at a 7.0% CAGR over the assessment period.
Based on end users, hospitals and diagnostic centers held more than 60% of the total market share in 2020. Sales in these segments are expected to grow on the back of an increasing number of diagnostic centers installed with PET imaging machines.
| Country | The USA |
|---|---|
| CAGR (2017 to 2022) | 4.9% |
| CAGR (2023 to 2023) | 5.4% |
| Valuation (2023 to 2033) | US$ 876.0 million |
| County | The United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 3.5% |
| CAGR (2023 to 2023) | 4.0% |
| Valuation (2023 to 2033) | US$ 41.0 million |
| Country | Germany |
|---|---|
| CAGR (2017 to 2022) | 3.4% |
| CAGR (2023 to 2023) | 4.1% |
| Valuation (2023 to 2033) | US$ 54.7 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 6% |
| CAGR (2023 to 2023) | 6.6% |
| Valuation (2023 to 2033) | US$ 98.9 million |
| Country | India |
|---|---|
| CAGR (2017 to 2022) | 5.4% |
| CAGR (2023 to 2023) | 4.8% |
| Valuation (2023 to 2033) | US$ 70.7 million |
The USA is expected to dominate the North American market, securing a CAGR of 5.4% with a valuation of US$ 876.0 million during the forecast period. The rising prevalence of cancer in the country underpins the need for advanced PET scanners, thereby creating sales prospects in the market.
According to the National Cancer Institute, in 2020, an estimated 1,806,590 new cancer cases were expected to be diagnosed in the United States, and 606,520 people were expected to die from the disease. The rate of new cases of cancer (cancer incidence) is 442.4 per 100,000 men and women per year (based on 2013 to 2017 cases), as per the National Cancer Institute. Therefore, this is expected to boost The USA positron emission tomography (PET) scanners market during the forecast period. Historically, the USA market secured a CAGR of 4.9% between 2017 and 2022.
China is capturing a CAGR of 6.6% with a valuation of US$ 98.9 million during the forecast period. Increasing efforts by manufacturers to incorporate value-based detectors in their PET machines are expected to drive sales in China.
The increasing adoption of LFS scintillation crystals for a new line of PET scanners is expected to boost the Chinese positron emission tomography (PET) scanners market. Historically, the China market secured a CAGR of 6% between 2017 and 2022.
India is capturing a CAGR of 4.8% with a valuation of US$ 70.7 million during the forecast period. The country's widespread technology diffusion drives the demand for positron emission tomography (PET) scanners. Also, the increasing number of PET scanning facilities in India is expected to continue boosting their installation over the assessment period.
The present key players, advanced technology in the healthcare sector, and growing investment are driving the Indian positron emission tomography (PET) scanners market. Historically, the Indian market secured a CAGR of 5.4% between 2017 and 2022.
Key players focus on novel and innovative approaches to develop positron emission tomography scanners. Production facility expansions, new product launches, and product approvals can strengthen their market presence
Some of the prominent players in the market are:
Recent Developments in the Positron Emission Tomography (PET) Scanners Market
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | The USA, Canada, Germany, The United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Segments Covered | Product Type, Application, Detector Type, End User, Region |
| Key Companies Profiled | GE Healthcare; Toshiba Corporation; Koninklijke Philips N.V.; Siemens Healthineers; Hitachi Medical Corporation; Positron Corporation; Mediso Ltd.; Yangzhou Kindsway Biotech Co.Ltd |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
As of 2023, the PET scanners market holds a valuation of about US$ 1.3 billion.
The PET scanners market is projected to attain a value of US$ 2.1 billion by 2033, driven by a CAGR of 5.3% between 2023 and 2033.
Innovative niches within the PET scanners market include hybrid imaging systems, compact mobile units, and AI-powered image analysis advancements.
With a projected market revenue of US$ 876.0 million by 2033, the United States exerts primary control over the PET scanners market.
Integrated AI diagnostics and improved radioisotope availability are driving trends shaping the PET scanners market landscape.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Full-ring PET Scanner 5.3.2. Partial-ring PET Scanner 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Oncology 6.3.2. Cardiology 6.3.3. Neurology 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Detector Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By Detector Type, 2017 to 2022 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Detector Type, 2023 to 2033 7.3.1. Bismuth Germanium Oxide 7.3.2. Lutetium Oxyorthosilicate 7.3.3. Gadolinium Oxyorthosilicate 7.3.4. Lutetium Fine Silicate 7.3.5. Lutetium Yttrium Orthosilicate 7.4. Y-o-Y Growth Trend Analysis By Detector Type, 2017 to 2022 7.5. Absolute $ Opportunity Analysis By Detector Type, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022 8.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Diagnostic Centers 8.3.3. PET Centers 8.3.4. Research Institute 8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022 9.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. Asia Pacific excluding Japan(APEJ) 9.3.6. Japan 9.3.7. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By Detector Type 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By Detector Type 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By Detector Type 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By Detector Type 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. The United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Nordic countries 12.2.1.7. BENELUX 12.2.1.8. Rest Of Western Europe 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By Detector Type 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By Detector Type 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Russia 13.2.1.2. Poland 13.2.1.3. Rest Of Eastern Europe 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By Detector Type 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By Detector Type 13.3.5. By End User 13.4. Key Takeaways 14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. India 14.2.1.3. ASEAN 14.2.1.4. Australia & New Zealand 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By Detector Type 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By Detector Type 14.3.5. By End User 14.4. Key Takeaways 15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By Detector Type 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By Detector Type 15.3.5. By End User 15.4. Key Takeaways 16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 16.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest Of MEA 16.2.2. By Product Type 16.2.3. By Application 16.2.4. By Detector Type 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product Type 16.3.3. By Application 16.3.4. By Detector Type 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. The USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Product Type 17.1.2.2. By Application 17.1.2.3. By Detector Type 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Product Type 17.2.2.2. By Application 17.2.2.3. By Detector Type 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Product Type 17.3.2.2. By Application 17.3.2.3. By Detector Type 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Product Type 17.4.2.2. By Application 17.4.2.3. By Detector Type 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Product Type 17.5.2.2. By Application 17.5.2.3. By Detector Type 17.5.2.4. By End User 17.6. The United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Product Type 17.6.2.2. By Application 17.6.2.3. By Detector Type 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Product Type 17.7.2.2. By Application 17.7.2.3. By Detector Type 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Product Type 17.8.2.2. By Application 17.8.2.3. By Detector Type 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Product Type 17.9.2.2. By Application 17.9.2.3. By Detector Type 17.9.2.4. By End User 17.10. Nordic countries 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Product Type 17.10.2.2. By Application 17.10.2.3. By Detector Type 17.10.2.4. By End User 17.11. BENELUX 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Product Type 17.11.2.2. By Application 17.11.2.3. By Detector Type 17.11.2.4. By End User 17.12. Russia 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Product Type 17.12.2.2. By Application 17.12.2.3. By Detector Type 17.12.2.4. By End User 17.13. Poland 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Product Type 17.13.2.2. By Application 17.13.2.3. By Detector Type 17.13.2.4. By End User 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Product Type 17.14.2.2. By Application 17.14.2.3. By Detector Type 17.14.2.4. By End User 17.15. India 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Product Type 17.15.2.2. By Application 17.15.2.3. By Detector Type 17.15.2.4. By End User 17.16. ASEAN 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Product Type 17.16.2.2. By Application 17.16.2.3. By Detector Type 17.16.2.4. By End User 17.17. Australia & New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Product Type 17.17.2.2. By Application 17.17.2.3. By Detector Type 17.17.2.4. By End User 17.18. Japan 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Product Type 17.18.2.2. By Application 17.18.2.3. By Detector Type 17.18.2.4. By End User 17.19. GCC countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Product Type 17.19.2.2. By Application 17.19.2.3. By Detector Type 17.19.2.4. By End User 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Product Type 17.20.2.2. By Application 17.20.2.3. By Detector Type 17.20.2.4. By End User 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Product Type 17.21.2.2. By Application 17.21.2.3. By Detector Type 17.21.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product Type 18.3.3. By Application 18.3.4. By Detector Type 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. GE Healthcare 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Toshiba Corporation 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Koninklijke Philips N.V. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Siemens Healthineers 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Hitachi Medical Corporation 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Positron Corporation 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Mediso Ltd. 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Yangzhou Kindsway Biotech Co.Ltd 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Oncovision 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Canon Medical Systems Corporation 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Positron Emission Tomography (PET) Scanners Market
